Browsing Tag
OncoSil Medical Limited
2 posts
OncoSil wins FDA HDE approval for rare bile duct cancer treatment
OncoSil Medical has received U.S. FDA Humanitarian Device Exemption approval for the OncoSil System in unresectable, non-metastatic distal cholangiocarcinoma, opening its first U.S. commercial pathway.
OncoSil Medical (ASX: OSL) rallies as FDA decision window opens
OncoSil is rallying into an FDA decision, but its trial was not designed to prove superiority. Can ASX turn clinical promise into sales?